F-652
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for F-652, covering 2019-09-09 to 2023-12-21. Get the full timeline:
Most recent: Clinical Trial Update: Study of F-652 (IL-22:IgG2 Fusion Protein) in Patients With Moderate to Severe COVID-19 [Phase 2]